These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1932 related items for PubMed ID: 21095116

  • 1. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
    Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C, European Organisation for Research and Treatment of Cancer.
    Eur J Cancer; 2011 Jan; 47(1):8-32. PubMed ID: 21095116
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P, Milazzo S, Liu JP, Zwahlen M, Birkmann J, Horneber M.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD007913. PubMed ID: 23076939
    [Abstract] [Full Text] [Related]

  • 7. Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis.
    Cooper KL, Madan J, Whyte S, Stevenson MD, Akehurst RL.
    BMC Cancer; 2011 Sep 23; 11():404. PubMed ID: 21943360
    [Abstract] [Full Text] [Related]

  • 8. Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
    Schippinger W, Holub R, Dandachi N, Bauernhofer T, Samonigg H.
    Oncology; 2006 Sep 23; 70(4):290-3. PubMed ID: 16899982
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience.
    Renwick W, Pettengell R, Green M.
    BioDrugs; 2009 Sep 23; 23(3):175-86. PubMed ID: 19627169
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.
    Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyran P, Tjan-Heijnen VC, Aapro MS.
    Eur J Cancer; 2003 Nov 23; 39(16):2264-72. PubMed ID: 14556916
    [Abstract] [Full Text] [Related]

  • 14. Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study.
    Almenar D, Mayans J, Juan O, Bueno JM, Lopez JI, Frau A, Guinot M, Cerezuela P, Buscalla EG, Gasquet JA, Sanchez J.
    Eur J Cancer Care (Engl); 2009 May 23; 18(3):280-6. PubMed ID: 19076208
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety.
    Mahtani R, Crawford J, Flannery SM, Lawrence T, Schenfeld J, Gawade PL.
    BMC Cancer; 2021 May 27; 21(1):621. PubMed ID: 34044798
    [Abstract] [Full Text] [Related]

  • 16. Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.
    Pettengell R, Aapro M, Brusamolino E, Caballero D, Coiffier B, Pfreundschuh M, Trneny M, Walewski J.
    Clin Drug Investig; 2009 May 27; 29(8):491-513. PubMed ID: 19591512
    [Abstract] [Full Text] [Related]

  • 17. Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
    Aapro M, Crawford J, Kamioner D.
    Support Care Cancer; 2010 May 27; 18(5):529-41. PubMed ID: 20191292
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.